Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Journal of the American College of Cardiology|November 1, 1983
Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluationsL DiCarlo, K Chatterjee, W W Parmley, et al.
Journal of Internal Medicine. Supplement|January 1, 1991
Effect of early intravenous rt-PA on infarct size estimated from serum enzyme activity: results from the TEAHAT StudyM Risenfors, M Hartford, M Dellborg, et al.
British Journal of Clinical Pharmacology|February 13, 2001
Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failureL Brynne, J L McNay, H G Schaefer, et al.
International Journal of Cardiology|May 1, 1986
Natural evolution of left ventricular haemodynamics following uncomplicated acute myocardial infarctionD P Murray, H M Corbeij, P H Dunselman, et al.
The American Journal of Medicine|March 1, 1985
Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalitiesC E Viquerat, P Daly, K Swedberg, et al.
The American Journal of Cardiology|October 1, 1984
Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failureK Swedberg, C Viquerat, J L Rouleau, et al.
American Heart Journal|February 1, 1985
Myocardial catecholamine balance during angina: effects of calcium entry blockers, verapamil and nifedipineJ L Rouleau, K Chatterjee, W W Parmley, et al.
The American Journal of Medicine|June 1, 1984
Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balanceD W Wahr, K Swedberg, M Rabbino, et al.
International Journal of Cardiology|November 15, 2013
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT studyL Tavazzi, K Swedberg, M Komajda, et al.
Circulation|March 23, 1999
Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator: implications for long-term efficacy and safety. The Metrix InvestigatorsH F Tse, C P Lau, J S Sra, et al.
Pageof 23